Search Results

Clinical efficacy, safety, and subjective experience based on ePRO in HIV‐infected individuals administered Bictegravir/Emtricitabine/Tenofovir Alafenamide in southwest China.

• Authors : Kong, Linghong¹ (AUTHOR); Xie, Xiaoxin² (AUTHOR); Fu, Yanhua² (AUTHOR)

• Source: Immunity, Inflammation & Disease. Aug2023, Vol. 11 Issue 8, p1-11. 11p.

Record details

Adverse reactions to cosmetics reported to the Chongqing adverse drug reaction monitoring centre system in China.

• Authors : Wang, Sha¹ (AUTHOR); Jiang, Yang¹ (AUTHOR); Lyu, Jing¹ (AUTHOR)

• Source: Contact Dermatitis (01051873). Mar2023, Vol. 88 Issue 3, p201-205. 5p.

Record details

Immune checkpoint inhibitor‐related adverse events in lung cancer: Real‐world incidence and management practices of 1905 patients in China.

• Authors : Shi, Yuequan¹ (AUTHOR); Fang, Jian² (AUTHOR); Zhou, Chengzhi³ (AUTHOR)

• Source: Thoracic Cancer. Feb2022, Vol. 13 Issue 3, p412-422. 11p.

Record details

Neoadjuvant chemoimmunotherapy for locally advanced esophageal squamous cell carcinoma: Data from literature review and a real‐world analysis.

• Authors : Zhang, Yao; Li, Huiting; Yu, Bo

Subjects: THERAPEUTIC use of antineoplastic agents; SQUAMOUS cell carcinoma; MEDICAL information storage & retrieval systemsCHINA

• Source: Thoracic Cancer; May2024, Vol. 15 Issue 13, p1072-1081, 10p

Record details

Bureaucratic manoeuvres and the local politics of climate change mitigation in China and India.

• Authors : Harrison, Tom¹ ; Kostka, Genia²

• Source: Development Policy Review. Jun2019 Supplement S1, Vol. 37, pO68-O84. 17p.

Record details

Effectiveness and safety of human type 5 recombinant adenovirus (H101) in malignant tumor with malignant pleural effusion and ascites: A multicenter, observational, real‐world study.

• Authors : Wang, Baocheng; Zhong, Chen; Liao, Zijun

Subjects: RESEARCH; PLEURAL effusions; PLEURA cancerCHINA

• Source: Thoracic Cancer; Oct2023, Vol. 14 Issue 30, p3051-3057, 7p

Record details

Chinese expert consensus on the application of pegylated recombinant human granulocyte colony‐stimulating factor during concurrent chemoradiotherapy (2023 edition).

• Authors : Wang, Jun; Li, Baosheng

Subjects: CONSENSUS (Social sciences); DRUG efficacy; MEDICAL radiologyCHINA

• Source: Precision Radiation Oncology; Sep2023, Vol. 7 Issue 3, p150-159, 10p

Record details

A phase II study of a doublet metronomic chemotherapy regimen consisting of oral vinorelbine and capecitabine in Chinese women with HER2-negative metastatic breast cancer.

• Authors : Yue Chai; Jiaxuan Liu; Mingxia Jiang

Subjects: THERAPEUTIC use of antimetabolites; THERAPEUTIC use of antineoplastic agents; DRUG efficacyCHINA

• Source: Thoracic Cancer; 8/15/2023, Vol. 14 Issue 23, p2259-2268, 10p

Record details

Osimertinib combined with bevacizumab as the first‐line treatment in non‐small cell lung cancer patients with brain metastasis harboring epidermal growth factor receptor mutations.

• Authors : Zhang, Ling; You, Yunhong; Liu, Xueli

Subjects: LUNG cancer; HYPERTENSION; DRUG efficacyCHINA

• Source: Thoracic Cancer; May2023, Vol. 14 Issue 15, p1355-1361, 7p

Record details

Views on traditional Chinese medicine amongst Chinese population: a systematic review of qualitative and quantitative studies.

• Authors : Chung, Vincent C. H.¹; Ma, Polly H. X.¹; Lau, Chun Hong¹

• Source: Health Expectations. Oct2014, Vol. 17 Issue 5, p622-636. 15p. 1 Diagram, 3 Charts.

Record details